Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Health Update Bahamas.
Press releases published on September 9, 2025
September 9, 2025
SoldierStrong, Gier Productions Announce Release of “The Heroism and Resiliency of 9/11” Documentary in 2026
Indeterminate
GlobeNewswire
September 9, 2025
SoCalBio Investor Conference Kicks Off October 1st with Keynote by SetPoint Medical CEO
Indeterminate
GlobeNewswire
September 9, 2025
University of St. Augustine for Health Sciences to Host Third Annual Psychiatric Mental Health Summit
Indeterminate
GlobeNewswire
September 9, 2025
Tiziana Life Sciences Announces Purchase of Shares by Chief Executive Officer
Indeterminate
GlobeNewswire
September 9, 2025
Honor Technology Announces New Appointments to Leadership Team
Indeterminate
GlobeNewswire
September 9, 2025
U.S. Oral Surgery Management Supports OMS Foundation
Indeterminate
GlobeNewswire
September 9, 2025
Capricor Therapeutics Responds to FDA Posting of Complete Response Letter (CRL) for Deramiocel
Indeterminate
GlobeNewswire
September 9, 2025
Silo Pharma Adds Japanese Patent to Expanding Global IP Portfolio for Licensed PTSD Drug
Indeterminate
GlobeNewswire
September 9, 2025
Celldex to Present at Morgan Stanley 23rd Annual Global Healthcare Conference
Indeterminate
GlobeNewswire
September 9, 2025
Tive Partners with AstraZeneca to Provide a Temperature Tracker for FluMist Home Delivery Program
Indeterminate
GlobeNewswire
September 9, 2025
Autonomix Medical, Inc. Announces Abstract Accepted for Podium Presentation at the 2025 CIRSE Annual Congress
Indeterminate
GlobeNewswire
September 9, 2025
Parexel Establishes New Global Headquarters in Raleigh’s North Hills Innovation District
Indeterminate
GlobeNewswire
September 9, 2025
Moleculin Accelerates Recruitment in Phase 3 Acute Myeloid Leukemia “MIRACLE” Clinical Trial
Indeterminate
GlobeNewswire
September 9, 2025
Teva’s Emrusolmin Granted U.S. FDA Fast Track Designation for Treatment of Multiple System Atrophy
Indeterminate
GlobeNewswire
September 9, 2025
Aphaia Pharma Initiates Second Phase 2 Trial of Oral Candidate in Obesity
Indeterminate
GlobeNewswire